These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 37492087)

  • 21. Efficacy and safety of two fixed-dose combinations of S-amlodipine and telmisartan (CKD-828) versus S-amlodipine monotherapy in patients with hypertension inadequately controlled using S-amlodipine monotherapy: an 8-week, multicenter, randomized, double-blind, Phase III clinical study.
    Ihm SH; Jeon HK; Cha TJ; Hong TJ; Kim SH; Lee NH; Yoon JH; Yoon N; Hwang KK; Jo SH; Youn HJ
    Drug Des Devel Ther; 2016; 10():3817-3826. PubMed ID: 27920497
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quanduzhong capsules for the treatment of grade 1 hypertension patients with low-to-moderate risk: A multicenter, randomized, double-blind, placebo-controlled clinical trial.
    Xu X; Tian W; Duan W; Pan C; Huang M; Wang Q; Yang Q; Wen Z; Tang Y; Xiong Y; Zhu Z; Liu Y; Wei D; Qi W; Ouyang X; Ying S; Wang X; Zhou Z; Li X; Cui Y; Yang S; Xu H
    Front Pharmacol; 2022; 13():1014410. PubMed ID: 36703729
    [No Abstract]   [Full Text] [Related]  

  • 23. Results of a 14-Week, Multicenter, Prospective, Randomized, Open-Label, Noninferiority Clinical Trial Comparing the Antihypertensive Effect and Edema Incidence of Lacidipine and Amlodipine in Older Korean Patients with Mild-to-Moderate Hypertension.
    Na JO; Seo HS; Choi CU; Lim HE; Kim JW; Kim EJ; Han SW; Rha SW; Park CG; Oh DJ;
    Curr Ther Res Clin Exp; 2013 Jun; 74():54-61. PubMed ID: 24384734
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amlodipine Besylate versus Candesartan Cilexetil in Hypertensive Patients - Office and Self-Measured Blood Pressure : A Randomised, Double-Blind, Comparative, Multicentre Trial.
    Trenkwalder P; Regourd E; Kluth-Pepper B; Sauerbrey-Wullkopf N
    Clin Drug Investig; 2005; 25(9):567-77. PubMed ID: 17532701
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Randomized, Double-blind, Multicenter, Phase III Study to Evaluate the Efficacy and Safety of Fimasartan/Amlodipine Combined Therapy Versus Fimasartan Monotherapy in Patients With Essential Hypertension Unresponsive to Fimasartan Monotherapy.
    Kim KI; Shin MS; Ihm SH; Youn HJ; Sung KC; Chae SC; Nam CW; Seo HS; Park SM; Rhee MY; Kim MH; Cha KS; Kim YJ; Kim JJ; Chun KJ; Yoo BS; Park S; Shin ES; Kim DS; Il Kim D; Kim KH; Joo SJ; Jeong JO; Shin J; Kim CH
    Clin Ther; 2016 Oct; 38(10):2159-2170. PubMed ID: 27502326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Efficacy and Tolerability of Irbesartan/Amlodipine Combination Therapy in Patients With Essential Hypertension Whose Blood Pressure Were not Controlled by Irbesartan Monotherapy.
    Lee HY; Min KW; Han KA; Kim JS; Ahn JC; Kim MH; Lee JB; Shin SH; Kim CJ; Kim KH; Cho DK; Choi J; Rhee MY; Her SH; Kim W; Na JO; Cho GY; Kim SY; Park GM; Lee BK; Jo SH; Lee BW; Sohn IS; Kim DI; Ihm SH; Lee SH; Chung JW; Cho EJ; Son JW; Oh SJ; Hwang JY; Jeong JO; Han KR; Yoon HJ; Seo SM; Chung WJ; Bae JW; Choi JH; Hyun BJ; Cha JE; Yoo SJ; Shin J
    Clin Ther; 2024 Jun; 46(6):481-489. PubMed ID: 38704294
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and tolerability of olmesartan medoxomil combined with amlodipine in patients with moderate to severe hypertension after amlodipine monotherapy: a randomized, double-blind, parallel-group, multicentre study.
    Volpe M; Brommer P; Haag U; Miele C
    Clin Drug Investig; 2009; 29(1):11-25. PubMed ID: 19067471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the efficacy and safety profiles of two fixed-dose combinations of antihypertensive agents, amlodipine/benazepril versus valsartan/hydrochlorothiazide, in patients with type 2 diabetes mellitus and hypertension: a 16-week, multicenter, randomized, double-blind, noninferiority study.
    Lee IT; Hung YJ; Chen JF; Wang CY; Lee WJ; Sheu WH
    Clin Ther; 2012 Aug; 34(8):1735-50. PubMed ID: 22784975
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of amlodipine besylate combined with acupoint application of traditional Chinese medicine nursing on the treatment of renal failure and hypertension by the PI3K/AKT pathway.
    Feng L; Su J; Chi R; Zhu Q; Lv S; Liang W
    Int J Mol Med; 2019 Apr; 43(4):1900-1910. PubMed ID: 30816438
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and Tolerability of Telmisartan/Amlodipine + Hydrochlorothiazide Versus Telmisartan/Amlodipine Combination Therapy for Essential Hypertension Uncontrolled With Telmisartan/Amlodipine: The Phase III, Multicenter, Randomized, Double-blind TAHYTI Study.
    Sung KC; Oh YS; Cha DH; Hong SJ; Won KH; Yoo KD; Rha SW; Ahn YK; Ahn JC; Jang JY; Hong TJ; Cho SK; Park SH; Hyon MS; Nam CW; Chae IH; Yoo BS; Song JM; Jeong JO; Yoon YW; Kim BS; Yang TH; Cho DK; Kim SH; Choi YJ; Ahn JH; Jeon DW; Kim HS
    Clin Ther; 2018 Jan; 40(1):50-63.e3. PubMed ID: 29248384
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
    Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of single-pill amlodipine/losartan versus losartan in patients with inadequately controlled hypertension after losartan treatment: a multicenter, double-blind, randomized phase III clinical trial.
    Zhang S; Li Y; Xu X; Xu R; Zhang L; Wan X; Yao Z; Sun Y; Liu Y; Bin J; Wang Z; Li S; Yang P; Xu X; Liang W; Gao X; Li X; Jia M; Ma G; Gu X; Hong C
    Front Cardiovasc Med; 2023; 10():1177166. PubMed ID: 37404731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Comparison of benazepril monotherapy to amlodipine plus benazepril in the treatment of patients with mild and moderate hypertension: a multicentre, randomized, double-blind, parallel-controlled study].
    Fan CM; Yan LR; Tao YK; Wang L; Li YQ; Gao MM; Wang YN; Li CX; Wang XW; Lu XL; Pang HM; Li YS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Jan; 39(1):57-60. PubMed ID: 21418799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of triple antihypertensive therapy with the olmesartan/amlodipine/hydrochlorothiazide combination.
    Volpe M; Christian Rump L; Ammentorp B; Laeis P
    Clin Drug Investig; 2012 Oct; 32(10):649-64. PubMed ID: 22909147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Randomized, controlled, parallel-group comparison of ambulatory and clinic blood pressure responses to amlodipine or enalapril during and after treatment in adult chinese patients with hypertension.
    Tomlinson B; Woo J; Thomas GN; Chau YM; Critchley JA
    Clin Ther; 2004 Aug; 26(8):1292-304. PubMed ID: 15476910
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of Masked Hypertension with a Chinese Herbal Formula: A Randomized, Placebo-Controlled Trial.
    Zhang DY; Cheng YB; Guo QH; Shan XL; Wei FF; Lu F; Sheng CS; Huang QF; Yang CH; Li Y; Wang JG
    Circulation; 2020 Nov; 142(19):1821-1830. PubMed ID: 33019798
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and Safety Study of Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide Combination Therapy in Patients with Hypertension Not Controlled with Olmesartan Medoxomil and Hydrochlorothiazide Combination Therapy: Results of a Randomized, Double-Blind, Multicenter Trial.
    Sohn IS; Kim CJ; Oh BH; Hong TJ; Park CG; Kim BS; Chung WB;
    Am J Cardiovasc Drugs; 2016 Apr; 16(2):129-38. PubMed ID: 26691333
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and Safety of Chinese Herbal Medicine Compared With Losartan for Mild Essential Hypertension: A Randomized, Multicenter, Double-Blind, Noninferiority Trial.
    Lai X; Dong Z; Wu S; Zhou X; Zhang G; Xiong S; Wu W; Cao R; Wang X; Hua Q; Du J; Fan J; Mao J; Jiang W; Yuan H; Chen Y; Xu Y; Li Z; Zhang J; Dong G; Zhen H; Ding R; Wu Z; Gao Y
    Circ Cardiovasc Qual Outcomes; 2022 Mar; 15(3):e007923. PubMed ID: 35105177
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of Fixed-dose Combinations of Amlodipine/Losartan Potassium/Chlorthalidone and Amlodipine/Losartan Potassium in Patients With Stage 2 Hypertension Inadequately Controlled With Amlodipine/Losartan Potassium: A Randomized, Double-blind, Multicenter, Phase III Study.
    Hong SJ; Jeong HS; Han SH; Chang KY; Hong BK; Lee BK; Chae SC; Kim WS; Park CG; Heo JH; Lee SU; Kim YD; Kim KS; Choi JH; Kang HJ; Kim JJ; Kang SM; Choi YJ; Shin JH; Chun KJ; Shin DG; Park SH; Kwan J; Choi YJ; Jeong MH; Chae JK; Kim DW; Cho JR; Han KR; Won KH; Park SH; Lee SK; Kim SH; Jung J; Kim CH
    Clin Ther; 2017 Oct; 39(10):2049-2060. PubMed ID: 28939406
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of 24-h ambulatory blood pressure monitoring to assess blood pressure control: a comparison of olmesartan medoxomil and amlodipine besylate.
    Chrysant SG; Marbury TC; Silfani TN
    Blood Press Monit; 2006 Jun; 11(3):135-41. PubMed ID: 16702822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.